Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities

DUBLIN, April 13, 2021 /PRNewswire/ -- The "Global Artificial Organ and Bionics Market (2020-2025) by Type, Technology, End user, Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The global artificial organ and bionics market is estimated to be USD 21.41 Bn in 2020 and is expected to reach USD 32.05 Bn by 2025, growing at a CAGR of 8.4 %.

Market Dynamics

The demand for organ donors is ever increasing, and is very high compared to the actual supply. This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high. Bionics and artificial organs are able to cater to the needs of those in need of organ transplantations and replacements. They can replicate the function of damaged organs.

Market Segmentation

The Global Artificial Organ and Bionics Market is segmented further based on Type, Technology, End user and Geography.

By Type, the market is classified into Artificial Organs includes Kidney, heart, lungs, liver, pancreas whereas Artificial Organs include Cochlear implant, exoskeleton, bionic limbs, vision bionics and brain bionics.

By Technology, the market is classified into mechanical and electronic bionics.

By Geography, Asia Pacific region is expected to rise and hold a larger share of this market in near future.

Recent Developments

1. In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.
2. In April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring.
3. In February 2018: A joint development agreement for an abdominal aortic aneurysm stent graft has been concluded between Jikei University School of Medicine and Asahi Kasei Corp.
4. In January 2018: Boston Scientific received an FDA approval for Spectra WaveWriterT Spinal Cord Stimulator System.

Company Profiles

Some of the companies covered in this report are Zimmer Biomet , Medtronic, Abbott , ABIOMED Inc. , Berlin Heart Gmbh , Biomet, Inc. , Boston Scientific Corporation , Edward Lifesciences Corporation , Ekso Bionics , Heartware International, Inc. , Iwalk, Inc. , Jarvik Heart, Inc. , SynCardia, etc.

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Artificial Organ and Bionics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing incidence of organ failure
4.2.1.2 Technological advancement in transplantation method
4.2.1.3 Developed tissue banks
4.2.1.4 Increasing aging population
4.2.2 Restraints
4.2.2.1 Shortage of organ donors
4.2.2.2 Ethical and cultural issues
4.2.2.3 Expensive Procedures
4.2.2.4 Risk of Compatibility Issues and Malfunctions
4.2.3 Opportunities
4.2.3.1 Advantageous in comparison prosthetics
4.2.3.2 Improving income levels & rising awareness could push demand in emerging economies
4.2.4 Challenges
4.2.4.1 Limited surgical expertise
4.2.4.2 High cost of development
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Artificial Organ & Bionics Market, By Type
6.1 Introduction
6.2 Artificial Organs
6.2.1 Kidney
6.2.2 Heart
6.2.3 Lungs
6.2.4 Liver
6.2.5 Pancreas
6.3 Artificial Bionics
6.3.1 Cochlear Implant
6.3.2 Exoskeleton
6.3.3 Bionic Limbs
6.3.4 Vision Bionics
6.3.5 Brain Bionics

7 Global Artificial Organ & Bionics Market, By Technology
7.1 Introduction
7.2 Mechanical Bionics
7.3 Electronic Bionics

8 Global Artificial Organ & Bionics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Russia
8.5.9 Rest of APAC
8.6 Rest of the World
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
8.6.5 Latin America

9 Competitive Landscape
9.1 IGR Competitive Quadrant
9.2 Market Share Analysis
9.3 Competitive Scenario
9.3.1 Mergers & Acquisitions
9.3.2 Agreement, Collaborations, & Partnerships
9.3.3 New Product Launches & Enhancements
9.3.4 Investments & Funding

10 Company Profiles
10.1 Zimmer Biomet
10.2 Medtronic
10.3 Abbott
10.4 ABIOMED, INC
10.5 Berlin Heart Gmbh
10.6 Biomet, Inc
10.7 Boston Scientific Corporation
10.8 Edward Lifesciences Corporation
10.9 Ekso Bionics
10.10 Heartware International, Inc
10.11 Iwalk, Inc.
10.12 Jarvik Heart, Inc.
10.13 SynCardia Systems, LLC
10.14 Gambro AB
10.15 Orthofix Holdings
10.16 LifeNet Health
10.17 Sonova
10.18 BionX Medical Technologies
10.19 Cochlear
10.20 Baxter International
10.21 SynCardia
10.22 Berlin Heart GmbH
10.23 Nipro Corporation
10.24 Ottobock

11 Appendix
11.1 Questionnaire

For more information about this report visit https://www.researchandmarkets.com/r/fwgk7b

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/worldwide-artificial-organ-and-bionics-industry-to-2025---advantageous-in-comparison-prosthetics-presents-opportunities-301267947.html

SOURCE Research and Markets